8:30 am
Morning Coffee & Networking
Achieving Regulatory Harmonization to Ensure the Acceleration of Novel Animal Vaccines into the Global Market
9:30 am Panel Discussion: Achieving Harmonization Amongst all Stakeholders (Developers, Regulators, Manufacturers & End Users) to Expedite Approvals & Achieve Maximum Return of Investment for Effective Animal Vaccine Technologies
Synopsis
- Where are the current gaps and misalignments amongst stakeholders to ensure success is achieved from submission through to approval of next generation animal health vaccines?
- How to balance the efficacy and safety concerns by regulatory agencies with consideration of the cost, practicality, and challenges faced in licensing the products?
10:30 am
Morning Break and Speed Networking
Improving the Economical Paradigm of Vaccine development for Animals with Cost & the Commercial Return in Mind
11:30 am Leveraging Successful Novel Technologies to Develop Therapeutically Valuable Vaccines for Multiple Diseases & Multiple Targets in Animals
Synopsis
- How we can utilize platform technologies to decrease vaccine manufacturing times and accelerate licensing processes to advance the rate and return of interest in animal vaccine production
- How to utilize platform technologies being used in human health and apply them to animal vaccines?
- How to develop a platform for specific target animals which can be used against a variety of diseases to reduce manufacturing and production costs of animal vaccines?
12:00 pm Reducing Vaccine Development Times & Manufacturing Costs through De-Risking
Synopsis
- De-risking is the process of reducing attrition rates in vaccine development through a robust Quality Design scheme
- A significant amount of time and money is spent in late development on re-work, which also results in early production failures
- By spending more time in early development and adopting a fast fail mindset, one can reduce overall cycle times and development costs
12:30 pm Streamlining Vaccine Manufacturing Costs: Exploring Innovative and Cost- Effective Production Approaches to Enhance both Safety and Efficacy
Synopsis
- How to leverage novel manufacturing techniques to face the barrier of funding in animal health to keep vaccine dosage costs low, especially for farm animals?
- How to harmonize with regulatory bodies to manufacture more vaccines simultaneously using modular technologies?
- Reflecting on the use of non-fixed manufacturing facilities and how these can drive a more economical vaccine production
1:00 pm
Networking Lunch Break
Exploring the Benefits of Disease & Species Dependent Non-Injectable Vaccine Administration in Both Farm & Companion Animals
2:00 pm Novel Platform Technology to Aid Prevent Necrotic Enteritis in Poultry
Synopsis
- Leveraging microbiome science and disease biology understanding, to develop animal vaccines with better efficacy & applicability
- Novel platform technology for targeted mucosal immunity
- Innovative vaccine to prevent and treat gut health disease
2:30 pm Inducing Mucosal Immunity Through the Use of Novel Platform Technologies
Synopsis
- How do mucosal vaccines differ from traditional injectable vaccines?
- How mucosal immunity is induced through novel technologies and the benefits of mucosal immunity in preventing diseases caused by bacterial, viral, and protozal pathogens
- How to understand which diseases can be more effectively controlled with mucosal vaccination over systemic vaccination to overcome low-efficacy systemic vaccines for animal disease?
3:00 pm Employing Plant Delivered Oral Vaccines to Combat Traditional Vaccine Challenges
Synopsis
- Understanding mucosal vs. systemic stimulation and which diseases need mucosal immunity for protection
- Navigating methods for producing and manufacturing plant delivered oral animal vaccines without compromising safety and efficacy
- Oral vaccination as a gateway to reducing farmer labor, increasing worker safety and decreasing biosecurity dangers